Cipla Q1 FY26 Results: With Rs 1,298 crore Q1 profit, Mumbai-based drug maker beats Street estimates; margin steady

Cipla Q1 FY26 Results: With Rs 1,298 crore Q1 profit, Mumbai-based drug maker beats Street estimates; margin steady

Cipla Q1 FY26 Results: Mumbai-headquartered pharmaceutical firm Cipla on Friday reported a 10.2 per cent year-on-year rise in consolidated net profit to RsĀ 1,298 crore for the quarter ended June 30, beating analysts’ expectations. Cipla shares spiked immediately after the earnings announcement as the results were announced during the market hours, finishing the day 3.0 per…

Read More
Sensex Crash Today: 30-scrip index sinks below 81,500 as market continues to fall for 2nd day; Bajaj Finance tumbles 5%

Sensex Crash Today: 30-scrip index sinks below 81,500 as market continues to fall for 2nd day; Bajaj Finance tumbles 5%

Domestic equity benchmarks registered sharp losses on Friday, July 25, amid selling pressure across most sectors. Financial stocks took a major blow after Bajaj Finance posted a weak set of quarterly numbers. Investors weighed a newly signed trade pact with the UK that will lower duties on several items, including whisky and cars.Ā  Both headline…

Read More
Stocks to Track Today (July 15): HCLTech, Sun Pharma, Tata Tech, LIC, HDFC Life, ICICI Pru, RVNL, M&M Financial Services & more

Stocks to Track Today (July 15): HCLTech, Sun Pharma, Tata Tech, LIC, HDFC Life, ICICI Pru, RVNL, M&M Financial Services & more

Stocks to Track on Tuesday (July 15): Domestic equity benchmarks Nifty50 and Sensex fell on Monday, continuing to decline for the fourth session in a row, as earnings did little to aid sentiment while investors globally continued to be wary of the US-triggered trade war. Selling pressure in IT, financial and energy shares continued to…

Read More